Altimmune Inc (ALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,424 | -5,484 | -2,097 | -39,171 | -14,664 |
| Depreciation Amortization | 1,317 | 230 | 154 | 25,243 | 682 |
| Income taxes - deferred | -59 | N/A | N/A | -6,150 | N/A |
| Accounts receivable | 2,449 | 832 | 556 | 344 | 1,259 |
| Accounts payable and accrued liabilities | -323 | -103 | -358 | 243 | 21 |
| Other Working Capital | 72 | -637 | -531 | 6,980 | 6,205 |
| Other Operating Activity | 5,367 | -11 | 164 | 3,121 | 2,263 |
| Operating Cash Flow | $-7,600 | $-5,173 | $-2,113 | $-9,389 | $-4,234 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -28,207 | N/A | N/A | N/A | N/A |
| PPE Investments | -1 | -1 | -1 | -961 | -954 |
| Purchase Sale Intangibles | -25 | -16 | -3 | -40 | -39 |
| Other Investing Activity | -25 | -16 | -3 | -40 | -39 |
| Investing Cash Flow | $-28,234 | $-17 | $-4 | $-1,001 | $-993 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -187 | -156 | N/A | N/A | N/A |
| Common Stock Issued | 12,699 | 12,699 | 12,699 | 37,426 | 4,358 |
| Other Financing Activity | -25 | 0 | 0 | -4,936 | -3,386 |
| Financing Cash Flow | $12,487 | $12,543 | $12,699 | $32,490 | $971 |
| Exchange Rate Effect | N/A | N/A | N/A | -50 | -50 |
| Beginning Cash Position | 34,353 | 34,353 | 34,353 | 12,304 | 12,304 |
| End Cash Position | 11,007 | 41,706 | 44,935 | 34,353 | 7,998 |
| Net Cash Flow | $-23,347 | $7,353 | $10,582 | $22,050 | $-4,306 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,600 | -5,173 | -2,113 | -9,389 | -4,234 |
| Capital Expenditure | -1 | -1 | -1 | -975 | -968 |
| Free Cash Flow | -7,601 | -5,174 | -2,114 | -10,364 | -5,202 |